ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Novavax Inc

Novavax Inc (NVAX)

12,68
-0,36
(-2,76%)
Geschlossen 10 Oktober 10:00PM
12,69
0,01
(0,08%)
Nach Börsenschluss: 1:59AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
12,69
Gebot
12,68
Fragen
12,70
Volumen
6.064.805
12,60 Tagesbereich 13,35
3,5324 52-Wochen-Bereich 23,8599
Marktkapitalisierung
Handelsende
13,04
Handelsbeginn
13,17
Letzte Trade
47
@
12.69
Letzter Handelszeitpunkt
Finanzvolumen
US$ 78.184.149
VWAP
12,8915
Durchschnittliches Volumen (3 Mio.)
6.544.418
Ausgegebene Aktien
160.093.639
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,72
Gewinn pro Aktie (EPS)
-3,4
Erlöse
983,71M
Nettogewinn
-545,06M

Über Novavax Inc

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to res... Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Novavax Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker NVAX. The last closing price for Novavax was US$13,04. Over the last year, Novavax shares have traded in a share price range of US$ 3,5324 to US$ 23,8599.

Novavax currently has 160.093.639 shares in issue. The market capitalisation of Novavax is US$2,09 billion. Novavax has a price to earnings ratio (PE ratio) of -3.72.

Option-Flow Novavax (NVAX)

Gesamtfluss

Bullisch

Nettoprämie

485k

Calls / Puts

275.00%

Käuf. / Verkä.

75.00%

OTM / ITM

200.00%

Sweeps

0.00%

NVAX Neueste Nachrichten

Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU

Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU PR Newswire GAITHERSBURG, Md., Oct. 9, 2024 GAITHERSBURG, Md., Oct. 9, 2024 /PRNewswire/ -- Novavax, Inc...

Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development

Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development PR Newswire GAITHERSBURG, Md., Sept. 25, 2024 Ruxandra Draghia-Akli, MD, PhD brings...

Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.

Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S. PR Newswire GAITHERSBURG, Md., Sept. 13, 2024 Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now...

Novavax to Participate in Upcoming September Conferences

Novavax to Participate in Upcoming September Conferences PR Newswire GAITHERSBURG, Md., Sept. 4, 2024 GAITHERSBURG, Md., Sept. 4, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global...

Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. PR Newswire GAITHERSBURG, Md., Aug. 30, 2024 Novavax expects pre-filled syringes will be broadly...

Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. PR Newswire GAITHERSBURG, Md., Aug. 30, 2024 Novavax expects pre-filled syringes will be broadly...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.373.0032467532512.3215.2212.18802016214.10157524CS
4-0.01-0.078740157480312.715.2211.09689067613.14319862CS
12-3.5-21.618282890716.1917.818.87654441813.13370428CS
268.27187.1040723984.4223.85993.811131274013.16255309CS
525.2670.79407806197.4323.85993.532495246689.97706587CS
156-149.18-92.1603756101161.87236.53.5324750482529.58504864CS
2607.94167.1578947374.75331.53883.5324665284754.92284713CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MNTSMomentus Inc
US$ 1,05
(153,01%)
487,35M
BNZIBanzai International Inc
US$ 4,95
(79,35%)
37,1M
LEELee Enterprises Inc
US$ 14,165
(47,09%)
588,89k
WWWW International Inc
US$ 1,60
(37,93%)
164,47M
KXINKaixin Holdings
US$ 0,2458
(36,56%)
160,33M
BYUBAIYU Holdings Inc
US$ 0,50
(-50,50%)
6,13M
SPGCSacks Parente Golf Inc
US$ 1,83
(-48,45%)
694,11k
SKKSKK Holdings Limited
US$ 3,92
(-35,21%)
3,4M
ALCEAlternus Clean Energy Inc
US$ 0,1037
(-28,04%)
12,63M
NISNNiSun International Enterprise Development Group Company Ltd
US$ 14,23
(-25,81%)
1,09M
MNTSMomentus Inc
US$ 1,05
(153,01%)
487,35M
NVDANVIDIA Corporation
US$ 132,65
(-0,18%)
246,9M
WWWW International Inc
US$ 1,60
(37,93%)
164,47M
KXINKaixin Holdings
US$ 0,2458
(36,56%)
160,33M
SQQQProShares UltraPro Short QQQ
US$ 7,17
(-2,32%)
134,45M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock